Journal
CLINICAL INFECTIOUS DISEASES
Volume 72, Issue 1, Pages 148-152Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciaa541
Keywords
emergency preparedness; infection prevention; healthcare economics; SARS-CoV-2
Categories
Funding
- National Heart, Lung, and Blood Institute [1K12HL138049-01]
- National Institutes of Health [1DP2AI144244-01]
- Veteran Affairs Partnered Evaluation Initiative
Ask authors/readers for more resources
Outbreaks and emergence of novel pathogens pose challenges in economic evaluations, requiring cost-effectiveness investigations and analyses for outbreak planning and containment in infection emergency preparedness response.
Outbreaks and emergence of novel pathogens present a challenge in economic evaluations of prevention strategies, due to unusually high levels of risk aversion and uncertainty. Here, we discuss cost-effectiveness investigations and interpretation of economic analyses in the context of outbreak planning and containment, and outline considerations for providers, administrators, patients, and policy makers for infection emergency preparedness response.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available